Prices delayed by at least 15 minutes | Print
Merck & Co (MRK)
Common StockThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Address
2000 Galloping Hill Road
Kenilworth
NJ
USA
07033
Telephone
+1 908 7401468
Forecast key dates
Name | Key Date |
---|---|
Merck & Co Inc First Quarter Earnings Conference Call for 2025 | 2025-04-25T09:00:00 |
Merck & Co Inc First Quarter Earnings Results for 2025 | 2025-04-25T00:00:00 |
Merck & Co Inc Annual Report for 2024 | 2025-02-26T00:00:00 |
Merck & Co Inc Fourth Quarter Earnings Conference Call for 2024 | 2025-01-31T09:00:00 |
Merck & Co Inc Fourth Quarter Earnings Results for 2024 | 2025-01-31T00:00:00 |
Merck & Co Inc Third Quarter Earnings Conference Call for 2024 | 2024-10-25T09:00:00 |
Merck & Co Inc Third Quarter Earnings Results for 2024 | 2024-10-25T00:00:00 |
Merck & Co Inc Second Quarter Earnings Conference Call for 2024 | 2024-08-01T08:00:00 |
Merck & Co Inc Second Quarter Earnings Results for 2024 | 2024-08-01T00:00:00 |
Merck & Co Inc Annual General Meeting for 2024 | 2024-05-23T09:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.